glp-1 gastroparesis law firm in kentucky gi obstruction attorney semaglutide gastric intestinal semaglutide diarrhea louisiana kentucky semaglutide gastrointestinal obstruction lawyer Wegovy® Lawsuit kentucky semaglutide gastrointestinal obstruction attorney semaglutide digestive blockage law office

The FDA's Category 2 designation means the substance may present significant safety risks when used in compounding and is prohibited in compounded medications pending further evaluation

Semaglutide is a long-lasting GLP-1 medication that is taken once weekly as an injection

This not only allows for faster recovery and healing but also makes it an excellent optimization tool, ensuring your body has the precise signals it needs to function at its peak

Quick Answer: Tirzepatide is not FDA-approved to treat Hashimoto's disease itself but may be used on-label for weight management in patients with Hashimoto's who meet obesity treatment criteria (BMI 30 or BMI 27 with comorbidities)